https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-09-21 / Int J Hyperthermia 2011;27(2):180-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-09-21 / Int J Hyperthermia 2011;27(2):180-62010-09-21 00:00:002019-02-15 09:17:26Intracavity hyperthermia in nasopharyngeal cancer: a phase III clinical study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-09-21 / Int J Hyperthermia 2010;26(8):748-64
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-09-21 / Int J Hyperthermia 2010;26(8):748-642010-09-21 00:00:002019-02-15 10:00:35Measurement and mathematical modeling of thermally induced injury and heat shock protein expression kinetics in normal and cancerous prostate cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-08-01 / Surgery 2010 Aug;148(2):325-34
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-08-01 / Surgery 2010 Aug;148(2):325-342010-08-01 00:00:002010-08-01 00:00:00Hyperthermia potentiates oncolytic herpes viral killing of pancreatic cancer through a heat shock protein pathway
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-04-29 / Lancet Oncol. 2010 Jun;11(6):561-70
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-04-29 / Lancet Oncol. 2010 Jun;11(6):561-702010-04-29 00:00:002019-02-15 09:37:53Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-03-17 / Cochrane Database Syst Rev 2010 Mar;(3):CD006377
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-03-17 / Cochrane Database Syst Rev 2010 Mar;(3):CD0063772010-03-17 00:00:002019-02-15 08:35:42Combined use of hyperthermia and radiation therapy for treating locally advanced cervix carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-03-01 / Immunol. Res. 2010 Mar;46(1-3):177-88
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-03-01 / Immunol. Res. 2010 Mar;46(1-3):177-882010-03-01 00:00:002019-02-15 09:17:28Fine-tuning immune surveillance by fever-range thermal stress
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-03-01 / Immunol. Res. 2010 Mar;46(1-3):137-54
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-03-01 / Immunol. Res. 2010 Mar;46(1-3):137-542010-03-01 00:00:002019-02-15 09:17:29Diverse immune mechanisms may contribute to the survival benefit seen in cancer patients receiving hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-01-01 / Int J Hyperthermia 2010;26(2):118-26
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-01-01 / Int J Hyperthermia 2010;26(2):118-262010-01-01 00:00:002010-01-01 00:00:00Regional abdominal hyperthermia combined with systemic chemotherapy for the treatment of patients with ovarian cancer relapse: Results of a pilot study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-01-01 / Int J Hyperthermia 2010;26(7):612-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-01-01 / Int J Hyperthermia 2010;26(7):612-72010-01-01 00:00:002010-01-01 00:00:00Hyperthermia combined with radiation therapy for superficial breast cancer and chest wall recurrence: a review of the randomised data
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-01-01 / Int J Hyperthermia 2010;26(2):108-17
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-01-01 / Int J Hyperthermia 2010;26(2):108-172010-01-01 00:00:002019-02-15 08:39:21Regional hyperthermia added to intensified preoperative chemo-radiation in locally advanced adenocarcinoma of middle and lower rectum
